Aberrant expression of receptors such as CCR4, CCR7, CCR10, CXCR3, and CXCR4 has been observed in MF and SS and is thought to contribute to disease progression, lymph node dissemination, and immune evasion (2). This evidence concerns the gene CCR4 and synovial sarcoma.